HOME | CONTACT | BLOG | SITE MAP   

Press Releases

VetStem Biopharma, Inc. Will Present Data on Two Clinical Conditions and an Industry Overview at the North American Veterinary Regenerative Medicine Association Conference

Regenerative Veterinary Medicine Company VetStem Biopharma, Inc. is proud to announce they are a Platinum Sponsor at the North American Veterinary Regenerative Medicine Association Conference where Dr Robert Harman will also be delivering three talks.

November 15, 2016 --

VetStem has been a long time supporter of the North American Veterinary Regenerative Medicine Association (NAVRMA), a non-profit industry association formed to foster continued research and distribution of information regarding veterinary regenerative medicine for all species. The 2016 Conference will be held in Amelia Island, Florida from November 17th-20th, where VetStem Biopharma will be a platinum sponsor of the event. Dr Robert Harman, VetStem’s founder and CEO, will be presenting on 3 topics during this event. He will present VetStem’s scientific information on two of their latest projects: Adipose-derived stem cells given intravenously improves epistaxis and objective bronchoscopy scoring in horses with exercise-induced pulmonary hemorrhage and A prospective, randomized, blinded and placebo-controlled efficacy study of intraarticular allogeneic adipose stem cells for the treatment of osteoarthritis in dogs. In addition, Dr. Harman was invited to present an industry overview titled “Evolution of Evidence and Regulation in Veterinary Regenerative Medicine.”

“The opportunity to speak at such a prestigious conference and to be a platinum sponsor is an honor and further recognition by the regenerative medicine community of the value of our scientific and educational contributions to the field of regenerative medicine over the past 14 years. We were here at the birth of this industry, have worked with FDA for many years, and intend to provide evidenced-based products for many years to come” stated Dr Harman.

VetStem has always held the belief that scientific evidence, continuing education, and regulatory guidance are the foundation of developing any new technology. VetStem first pioneered adipose-derived stem cell therapy for use in horses for tendon injuries, as an alternative to euthanasia. Just two years after the first horse was treated, VetStem treated the first cat and dog. In 2007 the first peer-reviewed, randomized, double-blinded, placebo controlled, multi-center study using VetStem therapy was published showing intra-articular injection of autologous adipose derived stem cells in the hip joint of a dog decreased patient discomfort and increased patient functional ability. That same year VetStem brought to market the Genesis Platelet Rich Plasma concentration system, as well as the first formal RACE-approved stem cell credentialing continuing education course.

In 2015, VetStem (now VetStem Biopharma) announced the successful completion and peer-reviewed publication of a pilot efficacy study for allogeneic stem cell therapy (93 dogs, multi-center, blinded, placebo controlled) in support of an FDA INADA. The primary end point was statistically significantly improved. VetStem also entered into a distribution and clinical research agreement with Pall LifeSciences on the V-PET™ platelet enhancement therapy system. The V-PET™ is supported by a JAVMA peer reviewed publication of a two center, double-blinded, randomized study in osteoarthritis in dogs.

VetStem is developing multiple stem cell products for FDA-approval that will provide for therapeutic solutions for difficult-to-treat medical conditions in the dog, cat and horse.





< Back to Press Releases     

 


  • Success Stories
    News
    Videos
    Blog
    Press Releases
    Facebook
    Twitter
     


      COMPANY
    Management
    Investors
    Contact Us
    Careers
    Privacy Policy
    SCIENCE
    FAQs
    Literature Refs
    Safety
    PET & HORSE OWNERS
    Dogs & Cats
    Horses
    Locate a Vet
    FAQs
    VETERINARIANS
    Vet Login /
    Credentialing

    Dogs & Cats
    Horses
    FAQs
    MEDIA ROOM
    Press Releases
    Success Stories
    News
    Videos
    Blog
    LOCATE A VET

    CONTACT US
     

    COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
    12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361